{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:55:57Z","timestamp":1778615757206,"version":"3.51.4"},"reference-count":43,"publisher":"The Society for Free Radical Research Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2015]]},"DOI":"10.3164\/jcbn.15-38","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T18:04:53Z","timestamp":1438193093000},"page":"113-120","source":"Crossref","is-referenced-by-count":18,"title":["Repressed TGF-\u03b2 signaling through CagA-Smad3 interaction as pathogenic mechanisms of &lt;i&gt;Helicobacter pylori&lt;\/i&gt;-associated gastritis"],"prefix":"10.3164","volume":"57","author":[{"given":"Thuy Trang","family":"Nguyen","sequence":"first","affiliation":[{"name":"Laboratory of Chemoprevention, Lee Gil Ya Cancer and Diabetes Institute, Gachon University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"CHA University Cancer Prevention Research Center, CHA Bio Complex"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Min","family":"Park","sequence":"additional","affiliation":[{"name":"CHA University Cancer Prevention Research Center, CHA Bio Complex"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Baik","family":"Hahm","sequence":"additional","affiliation":[{"name":"CHA University Cancer Prevention Research Center, CHA Bio Complex"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Jae","family":"Lee","sequence":"additional","affiliation":[{"name":"Laboratory of Chemoprevention, Lee Gil Ya Cancer and Diabetes Institute, Gachon University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Blaser MJ, Atherton JC. <i>Helicobacter pylori<\/i> persistence: biology and disease. J Clin Invest 2004; 113: 321\u2013333.","DOI":"10.1172\/JCI20925"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Ernst PB, Crowe SE, Reyes VE. How does <i>Helicobacter pylori<\/i> cause mucosal damage? The inflammatory response. Gastroenterology 1997; 113 (6 Suppl): S35\u2013S42; discussion S50.","DOI":"10.1016\/S0016-5085(97)80009-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Koch M, Meyer TF, Moss SF. Inflammation, immunity, vaccines for <i>Helicobacter pylori<\/i> infection. Helicobacter 2013; 18 Suppl 1: 18\u201323.","DOI":"10.1111\/hel.12073"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Atherton JC, Blaser MJ. Coadaptation of <i>Helicobacter pylori<\/i> and humans: ancient history, modern implications. J Clin Invest 2009; 119: 2475\u20132487.","DOI":"10.1172\/JCI38605"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Lee JS, Paek NS, Kwon OS, Hahm KB. Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling (SOCS) expression and signaling in <i>Helicobacter pylori<\/i> infection: a novel mechanism. J Gastroenterol Hepatol 2010; 25: 194\u2013202.","DOI":"10.1111\/j.1440-1746.2009.06127.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Jenkins BJ, Grail D, Nheu T, et al. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat Med 2005; 11: 845\u2013852.","DOI":"10.1038\/nm1282"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Lee IO, Kim JH, Choi YJ, et al. <i>Helicobacter pylori<\/i> CagA phosphorylation status determines the gp130-activated SHP2\/ERK and JAK\/STAT signal transduction pathways in gastric epithelial cells. J Biol Chem 2010; 285: 16042\u201316050.","DOI":"10.1074\/jbc.M110.111054"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Bronte-Tinkew DM, Terebiznik M, Franco A, et al. <i>Helicobacter pylori<\/i> cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway <i>in vitro<\/i> and <i>in vivo<\/i>. Cancer Res 2009; 69: 632\u2013639.","DOI":"10.1158\/0008-5472.CAN-08-1191"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Hatakeyama M, Higashi H. <i>Helicobacter pylori<\/i> CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci 2005; 96: 835\u2013843.","DOI":"10.1111\/j.1349-7006.2005.00130.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Rohde M, P\u00fcls J, Buhrdorf R, Fischer W, Haas R. A novel sheathed surface organelle of the <i>Helicobacter pylori<\/i> cag type IV secretion system. Mol Microbiol 2003; 49: 219\u2013234.","DOI":"10.1046\/j.1365-2958.2003.03549.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Higashi H, Yokoyama K, Fujii Y, et al. EPIYA motif is a membrane-targeting signal of <i>Helicobacter pylori<\/i> virulence factor CagA in mammalian cells. J Biol Chem 2005; 280: 23130\u201323137.","DOI":"10.1074\/jbc.M503583200"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Selbach M, Moese S, Hauck CR, Meyer TF, Backert S. Src is the kinase of the <i>Helicobacter pylori<\/i> CagA protein <i>in vitro<\/i> and <i>in vivo<\/i>. J Biol Chem 2002; 277: 6775\u20136778.","DOI":"10.1074\/jbc.C100754200"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Hatakeyama M. <i>Helicobacter pylori<\/i> CagA -- a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer 2006; 119: 1217\u20131223.","DOI":"10.1002\/ijc.21831"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Wen S, Moss SF. <i>Helicobacter pylori<\/i> virulence factors in gastric carcinogenesis. Cancer Lett 2009; 282: 1\u20138.","DOI":"10.1016\/j.canlet.2008.11.016"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Massagu\u00e9 J. TGF\u03b2 signalling in context. Nat Rev Mol Cell Biol 2012; 13: 616\u2013630.","DOI":"10.1038\/nrm3434"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Konkel JE, Chen W. Balancing acts: the role of TGF-\u03b2 in the mucosal immune system. Trends Mol Med 2011; 17: 668\u2013676.","DOI":"10.1016\/j.molmed.2011.07.002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Wrzesinski SH, Wan YY, Flavell RA. Transforming growth factor-beta and the immune response: implications for anticancer therapy. Clin Cancer Res 2007; 13 (18 Pt 1): 5262\u20135270.","DOI":"10.1158\/1078-0432.CCR-07-1157"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Massagu\u00e9 J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005; 19: 2783\u20132810.","DOI":"10.1101\/gad.1350705"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Schmierer B, Hill CS. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007; 8: 970\u2013982.","DOI":"10.1038\/nrm2297"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Hahm KB, Lee KM, Kim YB, et al. Conditional loss of TGF-beta signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Aliment Pharmacol Ther 2002; 16 Suppl 2: 115\u2013127.","DOI":"10.1046\/j.1365-2036.16.s2.3.x"},{"key":"21","unstructured":"21 Myeroff LL, Parsons R, Kim SJ, et al. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 1995; 55: 5545\u20135547."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Howe JR, Bair JL, Sayed MG, et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 2001; 28: 184\u2013187.","DOI":"10.1038\/88919"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4\/DPC4 gene in juvenile polyposis. Science 1998; 280: 1086\u20131088.","DOI":"10.1126\/science.280.5366.1086"},{"key":"24","unstructured":"24 Boivin GP, Molina JR, Ormsby I, Stemmermann G, Doetschman T. Gastric lesions in transforming growth factor beta-1 heterozygous mice. Lab Invest 1996; 74: 513\u2013518."},{"key":"25","unstructured":"25 Takaku K, Miyoshi H, Matsunaga A, Oshima M, Sasaki N, Taketo MM. Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res 1999; 59: 6113\u20136117."},{"key":"26","unstructured":"26 Fox FE, Capocasale RJ, Ford HC, Lamb RJ, Moore JS, Nowell PC. Transforming growth factor-beta inhibits human T-cell proliferation through multiple targets. Lymphokine Cytokine Res 1992; 11: 299\u2013305."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Petit-Koskas E, Genot E, Lawrence D, Kolb JP. Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta. Eur J Immunol 1988; 18: 111\u2013116.","DOI":"10.1002\/eji.1830180117"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693\u2013699.","DOI":"10.1038\/359693a0"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Monteleone G, Del Vecchio Blanco G, Palmieri G, et al. Induction and regulation of Smad7 in the gastric mucosa of patients with <i>Helicobacter pylori<\/i> infection. Gastroenterology 2004; 126: 674\u2013682.","DOI":"10.1053\/j.gastro.2003.11.048"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Jo Y, Han SU, Kim YJ, et al. Suppressed gastric mucosal TGF-\u03b21 increases susceptibility to <i>H. pylori<\/i>-induced gastric inflammation and ulceration: a stupid host defense response. Gut Liver 2010; 4: 43\u201353.","DOI":"10.5009\/gnl.2010.4.1.43"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Higashi H, Tsutsumi R, Fujita A, et al. Biological activity of the <i>Helicobacter pylori<\/i> virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A 2002; 99: 14428\u201314433.","DOI":"10.1073\/pnas.222375399"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Lee HJ, Lee JK, Miyake S, Kim SJ. A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-beta signaling by blocking TGF-beta-induced formation of Smad3-Smad4 complexes. J Biol Chem 2004; 279: 2666\u20132672.","DOI":"10.1074\/jbc.M310591200"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Lee HJ, Yun CH, Lim SH, et al. SRF is a nuclear repressor of Smad3-mediated TGF-beta signaling. Oncogene 2007; 26: 173\u2013185.","DOI":"10.1038\/sj.onc.1209774"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Selbach M, Moese S, Hurwitz R, Hauck CR, Meyer TF, Backert S. The <i>Helicobacter pylori<\/i> CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J 2003; 22: 515\u2013528.","DOI":"10.1093\/emboj\/cdg050"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Murata-Kamiya N, Kurashima Y, Teishikata Y, et al. <i>Helicobacter pylori<\/i> CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007; 26: 4617\u20134626.","DOI":"10.1038\/sj.onc.1210251"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Massagu\u00e9 J. TGFbeta in cancer. Cell 2008; 134: 215\u2013230.","DOI":"10.1016\/j.cell.2008.07.001"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Li Z, Li J. Local expressions of TGF-beta1, TGF-beta1RI, CTGF, and Smad-7 in <i>Helicobacter pylori<\/i>-associated gastritis. Scand J Gastroenterol 2006; 41: 1007\u20131012.","DOI":"10.1080\/00365520600554477"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Piek E, Ju WJ, Heyer J, et al. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 2001; 276: 19945\u201319953.","DOI":"10.1074\/jbc.M102382200"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Dennler S, Huet S, Gauthier JM. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene 1999; 18: 1643\u20131648.","DOI":"10.1038\/sj.onc.1202729"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Yagi K, Goto D, Hamamoto T, Takenoshita S, Kato M, Miyazono K. Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3. J Biol Chem 1999; 274: 703\u2013709.","DOI":"10.1074\/jbc.274.2.703"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Yang X, Letterio JJ, Lechleider RJ, et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 1999; 18: 1280\u20131291.","DOI":"10.1093\/emboj\/18.5.1280"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Hatakeyama M. <i>Helicobacter pylori<\/i> and gastric carcinogenesis. J Gastroenterol 2009; 44: 239\u2013248.","DOI":"10.1007\/s00535-009-0014-1"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Peek RM Jr. Orchestration of aberrant epithelial signaling by <i>Helicobacter pylori<\/i> CagA. Sci STKE 2005; 277: pe14.","DOI":"10.1126\/stke.2772005pe14"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/57\/2\/57_15-38\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T17:43:39Z","timestamp":1567014219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/57\/2\/57_15-38\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.15-38","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}